Interstitial Lung Disease Trial, Recruiting NCT07173348 Sponsor: University Hospital, Geneva Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT07173348
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People with a primary diagnosis of one of the following: metastatic cancer, COPD (a lung condition) at stage B or E or higher, ILD (a group of lung diseases causing scarring), or CHF (a condition where the heart doesn't pump blood as well as it should)
  • People experiencing breathlessness rated at a certain level of severity — specifically, a score of NYHA Stage II or higher, or mMRC Grade 2 or higher (confirm with trial site for how these are assessed)

Who may not be able to join:

  • People who have received hypnosis treatment within the last 12 months
  • People whose life expectancy is estimated to be less than 6 months
  • People who have taken part in a pulmonary rehabilitation (breathing exercise) program within the last 6 months
  • People who have been hospitalised within the last 30 days
  • People who are unable to attend 3 outpatient (non-hospital-stay) appointments at the hospital, scheduled approximately two weeks apart
  • People with a condition that would make it difficult to complete questionnaires, such as cognitive impairment or significant hearing difficulties
  • People for whom hypnosis is considered unsuitable due to a psychiatric disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa Hentsch, Dr med, University Hospital, Geneva

Phone: +41 22 305 66 12

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Geneva
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 February 2028

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Chronic Respiratory Questionnaire (CRQ): sub scale mastery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov